Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.9M Buy
71,580
+95
+0.1% +$32.5K 2.13% 22
2026
Q1
$25.2M Sell
71,485
-866
-1% -$309K 2.19% 22
2025
Q4
$23.7M Sell
72,351
-836
-1% -$265K 2.13% 23
2025
Q3
$20.7M Buy
73,187
+619
+0.9% +$180K 1.82% 31
2025
Q2
$20.3M Buy
72,568
+6,565
+10% +$1.86M 1.9% 30
2025
Q1
$20.6M Buy
66,003
+1,285
+2% +$379K 2.02% 30
2024
Q4
$16.9M Buy
64,718
+2,041
+3% +$606K 1.68% 39
2024
Q3
$20.2M Sell
62,677
-1,303
-2% -$426K 1.93% 29
2024
Q2
$20M Buy
63,980
+77
+0.1% +$22.6K 2.07% 20
2024
Q1
$18.2M Buy
63,903
+335
+0.5% +$98K 1.91% 30
2023
Q4
$18.3M Buy
63,568
+1,539
+2% +$419K 2.08% 25
2023
Q3
$16.7M Buy
62,029
+2,525
+4% +$630K 2.05% 23
2023
Q2
$13.2M Buy
59,504
+58,490
+5,768% +$13.6M 1.5% 40
2023
Q1
$245K Sell
1,014
-300
-23% -$73.6K 0.03% 98
2022
Q4
$345K Buy
+1,314
New +$352K 0.07% 52
2021
Q4
Sell
-1,014
Closed -$216K 103
2021
Q3
$216K Sell
1,014
-25
-2% -$5.75K 0.1% 27
2021
Q2
$253K Sell
1,039
-125
-11% -$30.8K 0.15% 20
2021
Q1
$290K Sell
1,164
-278
-19% -$66.3K 0.04% 81
2020
Q4
$332K Buy
1,442
+22
+2% +$5.07K 0.04% 75
2020
Q3
$361K Buy
1,420
+56
+4% +$13.9K 0.05% 66
2020
Q2
$322K Sell
1,364
-27
-2% -$6.16K 0.05% 70
2020
Q1
$282K Buy
1,391
+177
+15% +$38.7K 0.05% 69
2019
Q4
$293K Sell
1,214
-224
-16% -$49.4K 0.04% 76
2019
Q3
$278K Sell
1,438
-104
-7% -$20K 0.04% 71
2019
Q2
$284K Buy
1,542
+224
+17% +$40.1K 0.04% 75
2019
Q1
$250K Buy
+1,318
New +$252K 0.04% 71

Other funds holding AMGN

Godsey & Gibb Inc's AMGN Position: Q2 2026 in Review

Godsey & Gibb Inc increased its Amgen (AMGN) stake by 0.13% in Q2 2026, buying an estimated $32.5K and bringing the position to 71,580 shares worth $25.9M. The position accounts for 2.13% of the portfolio, ranked #22.

Godsey & Gibb Inc first reported a position in AMGN in Q1 2019 and has held it in 26 quarters since. 1,151 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Godsey & Gibb Inc held 71,580 shares of Amgen worth $25.9M as of Q2 2026.
  • Godsey & Gibb Inc bought 95 Amgen shares in Q2 2026, an estimated $32.5K.
  • Amgen made up 2.13% of Godsey & Gibb Inc's portfolio in Q2 2026, its #22 holding.
  • Godsey & Gibb Inc first reported a position in Amgen in Q1 2019 and has held it in 26 quarters since.
  • 1,151 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Godsey & Gibb Inc's 13F filing for Q2 2026, filed 13 Jul 2026.